期刊文献+

血清胱抑素C水平对妊娠期高血压疾病发生及妊娠结局的研究 被引量:1

Study on serum cystatin level in the occurrence of pregnancy-induced hypertension and pregnancy outcome.
下载PDF
导出
摘要 目的探讨血清胱抑素C水平对妊娠妇女妊娠期高血压疾病的发生及妊娠结局的影响。方法采用回顾性方法选取2016年1月-2018年6月在昆明市妇幼保健院产科入院分娩的产妇为观察对象,按孕妇产前血清胱抑素C水平四分位数数值进行分组:分为A、B、C、D四组,比较血清胱抑素C水平四分位分组间母亲人口统计学、妊娠期高血压疾病发病率以及妊娠结局的差异。结果随血清胱抑素C水平的增加,妊娠期高血压疾病的发生率明显增加,妊娠期不良结局增加。 Objective To investigate the effect of serum cystatin levels on pregnancy outcomes of pregnant women with hypertension during pregnancy.Methods The retrospective method was used to select the women who were delivered in the obstetrics department of Kunming Maternity and Child Health Hospital from January 2016 to June 2018 as observation objects,and were grouped according to the quartile value of serum prenatal serum cystatin levels:Differences in maternal demographics,the incidence of hypertension during pregnancy,and pregnancy outcomes were compared between the four quartiles of serum cystatin levels in groups A,B,C,and D.Results With the increase of serum cystatin levels,the incidence of maternal hypertension during pregnancy increased significantly,and adverse pregnancy outcomes increased.
作者 沈翠花 杨奕梅 杨丽娟 郭小娟 李佳 Shen Cuihua;Yang Yimei;Yang Lijuan(Obstetrics Department of Kunming Maternity and Child Health Hospital,KunmingYunnan 650031,China)
出处 《云南医药》 CAS 2021年第1期1-3,共3页 Medicine and Pharmacy of Yunnan
关键词 血清胱抑素C 妊娠期高血压疾病 妊娠结局 Serum cystatin Pregnancy-induced hypertension Pregnancy outcomes
  • 相关文献

参考文献3

二级参考文献52

  • 1乐杰.妇产科学[M].6版.北京:人民卫生出版社,2003:354
  • 2American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 3Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 4Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 5Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 6Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 7Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 8Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.
  • 9Churchill D, Beevers GD, Meher S, et al, Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007, 24 (1):CD004451.
  • 10McCoy S, Baldwin K. Pharmacotherapeutie options for the treatment of preeelampsia[J]. Am J Health Syst Pharm, 2009, 66(4):337-344.

共引文献1208

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部